Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510974 · ClinicalTrials.gov registry record
RAAS and Arterial Stiffness in SCI
A clinical trial, sponsored by James J. Peters Veterans Affairs Medical Center.
- Completed
- Registry status
- 33
- Enrollment target
NCT04510974: Completed study, sponsored by James J. Peters Veterans Affairs Medical Center.
NCT04510974 is a clinical trial that has completed, run by James J. Peters Veterans Affairs Medical Center. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04510974 has completed, sponsored by James J. Peters Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The study is examining differences in central arterial stiffness, orthostatic changes in blood pressure, norepinephrine, and plasma renin in individuals with spinal cord injury compared with age-matched uninjured controls.
Primary Outcome
Determine average pulse wave velocity among the three groups.
Interventions
- OTHER Spinal Cord Injury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-06-30 |
| Est. Completion | 2020-12-01 |
What the finished NCT04510974 record still lists
NCT04510974 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Injury is the first listed.
NCT04510974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04510974 about?
NCT04510974 is a clinical study titled "RAAS and Arterial Stiffness in SCI". The study is examining differences in central arterial stiffness, orthostatic changes in blood pressure, norepinephrine, and plasma renin in individuals with spinal cord injury compared with age-matched uninjured controls.
What is the current status of trial NCT04510974?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2018-06-30. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT04510974?
The interventions under investigation include: Spinal Cord Injury (OTHER).
Who is sponsoring clinical trial NCT04510974?
This trial is sponsored by James J. Peters Veterans Affairs Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI